Linxia Deng Yaxian Chen Xiufen Hu Jianhua Zhou Yu Zhang
10.3389/fimmu.2021.708463
Front Immunol
2021 Oct 4;12:708463.
child cyclosporine a (csa) interstitial lung disease pirfenidone systemic lupus erythematosus
CC BY
https://pubmed.ncbi.nlm.nih.gov/34671344/
Cyclosporine / therapeutic use Lung Diseases, Interstitial / drug therapy Lung Diseases, Interstitial / etiology Lupus Erythematosus, Systemic / complications Lupus Erythematosus, Systemic / drug therapy Pyridones / therapeutic use
Cyclosporine / therapeutic use Lung Diseases, Interstitial / drug therapy Lung Diseases, Interstitial / etiology Lupus Erythematosus, Systemic / complications Lupus Erythematosus, Systemic / drug therapy Pyridones / therapeutic use Case Reports Research Support, Non-U.S. Gov't Anti-Inflammatory Agents, Non-Steroidal Child, Preschool Humans Immunosuppressive Agents / therapeutic use Male Anti-Inflammatory Agents, Non-Steroidal Immunosuppressive Agents Pyridones Cyclosporine pirfenidone
PMC8521163
34671344
Case Report: Successful Treatment of Refractory Interstitial Lung Disease With Cyclosporine A and Pirfenidone in a Child With SLE
2021